Novel Psychoactive Substances (NPS’s)

Written by: Alan Baker6th September, 2018

Bericon is being increasingly asked to review the above information and offer an assessment of whether an individual’s suggested passive exposure to an NPS may have led to them failing an MDT for a given substance or its metabolite. We are able to prepare reports which offers comment on the above scenario and, given the…